JNPMEDI

Exhibitor

JNPMEDI is an eClinical & Safety solutions provider offering solutions of the highest data integrity and operational efficiency.

JNPMEDI’s proprietary platform, Maven Clinical Cloud offers a suite of tools (Safety, EDC, eCOA, Docs, etc.) to enable the end-to-end management of product lifecycle within a single ecosystem. Since its official launch in 2022, Maven Clinical Cloud has been used in more than 100 clinical trials across 20 different countries.

Maven Safety is our intuitive, validated, and regulatory-compliant cloud system for Pharmacovigilance, that is backed by blockchain technology.

The Maven Safety platform integrates automated case intake, case processing, E2B (R3) compliant regulatory submissions and reporting gateways; as well as dashboards and analytics to support data mining and analysis

Maven Safety Value proposition

  • Safety SaaS: Scalable and flexible cloud system for Pharmacovigilance
  • Rapid deployment: Keeping customizations to a minimum and providing ample configuration choices

  • Safety Consulting: Dedicated SPOC (Single Point of Contact) for technical/functional support

  • Blockchain Audit trail: First in industry blockchain audit trail for Pharmacovigilance ensures tamper-proof data

Maven Safety: Key features

  • Enhanced User Onboarding
    • Adaptable, Swift, User-Friendly
  • Fit for purpose pricing
    • Customized and Lean pricing
  • Configurable workflows
    • Standard vs On-Demand
  • Integration with Maven CDMS
    • Auto transfer of SAEs/SUSARs and Auto-reconciliation
  • In-built Automations
    • Intake, Narratives, Alerts & notifications
  • Agile & Agnostic
    • Open API supports integration with external systems


website

Get Involved At Drug Safety Congress Americas

 

For Sponsorship and Exhibition opportunities

Semen Sen
semen.sen@terrapinn.com
t/ + 646-619-1793

 

 

To Speak


Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

Marketing & Press Opportunities


Kaylie Brogan
kaylie.brogan@terrapinn.com
t/ +1 646 619 1785